Advanced Bifurcation Systems

Transforming Stenting Practice In Coronary Bifurcation Disease

News and Events

ABS® News & Announcements

BioSpace – ABS Announces Livermore Manufacturing Facility

Family Office Networks Partners With ABS – says our platform may become the “standard of care”

MorningStar – Thomas O’Neill Joins ABS Board of Directors

Bloomberg- Advanced Bifurcation Add Tom O’Neill to Its Board

Silicon Investor – ABS Announces 2018 Expansion Plans

World News – ABS Amasses 34 Patents With Many More In Process

World News – ABS Announces Plans To Raise $20M, Appoints Ken Richards CFO

Advanced Bifurcation Systems® Press Resources

Company Profiles

Inc Profile On Advanced Bifurcation Systems

ABS Profile and News On BioSpace

Patents

Patent portfolio as of Q3 2018

36 Issued
- 12 issued by the U.S. Patent Office
- 24 International
- Includes Patents Issued by China, Australia, UK and Canada
12 Additional Patents Pending

Leave a Reply

Contact Us

7419 Southfront Road
Livermore, CA 94551

(877) 413-5845
(877) 413-5901 FAX

Request Information

Notice

This site and all contents are copyright © 2017 Advanced Bifurcation Systems unless otherwise noted. All information is presented for informational purposes and no specific medical claims have been made or should be implied. The company has submitted a proposal to the U.S. Federal Drug Administration (“FDA”) for a clinical study leading to an IDE for its bifurcation technology. No statements on this site have been verified by the FDA or any governing body.